Page last updated: 2024-08-25

zoledronic acid and Adenocarcinoma Of Kidney

zoledronic acid has been researched along with Adenocarcinoma Of Kidney in 46 studies

Research

Studies (46)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	16 (34.78)	29.6817
2010's	28 (60.87)	24.3611
2020's	2 (4.35)	2.80

Authors

Authors	Studies
Gao, Q; Guo, J; You, H; Zhao, Y; Zhu, H	1
Harada, H; Hayakawa, K; Katagiri, H; Miyazawa, K; Nagakura, H; Nakamura, N; Nozaki, M; Ogawa, H; Shikama, N; Uchida, N; Wada, H; Yamada, K	1
Harada, H; Hosaka, S; Katagiri, H; Murata, H; Niwakawa, M; Takahashi, M; Wasa, J	1
Omrčen, T; Rini, B; Schmidinger, M; Sella, A; Szczylik, C; Torday, L; Vrdoljak, E	1
Agerbaek, M; Donskov, F; Fode, K; Folkmar, TB; Smidt-Hansen, T	1
Fujii, Y; Kihara, K; Kijima, T; Koga, F; Tatokoro, M; Yoshida, S	1
Bahleda, R; Escudier, B; Gueutin, V; Izzedine, H; Rouvier, P; Soria, JC; Varga, A	1
Alcaraz, A; Alvarez-Ossorio, JL; Bellmunt, J; Calderero, V; Carles, J; Chirivella, I; Climent, M; Comet-Batlle, J; Contreras, JA; de la Piedra, C; Esteban, E; González-Del Alba, A; González-Enguita, C; González-Gragera, B; González-López, R; Lara, PC; Lassa, A; León-Mateos, L; Mahillo-Fernández, I; Mañas, A; Mellado, B; Méndez, MJ; Meseguer, C; Morote, J; Murias, A; Samper, P; Segarra, J; Unda, M; Vázquez, F	1
Levin, L; Luder, L	1
Choueiri, TK; Heng, DY; Lin, X; McKay, RR; Perkins, JJ; Simantov, R	1
Froehner, M; Hakenberg, OW; Hölscher, T; Wirth, MP	1
Broom, RJ; Deva, S; Duffey, S; Findlay, MP; Fong, PC; Forgeson, G; Grey, A; Hanning, FJ; Harris, DL; Hinder, V; Jameson, MB; North, RT; O'Donnell, A; Pollard, S; Proctor, J; Sharples, K	1
Bedogni, A; Bettini, G; Bonacina, R; Campisi, G; Di Fede, O; Fusco, V; Guglielmini, P; Lo Re, G; Merigo, E; Paglino, C; Porta, C; Saia, G; Scoletta, M; Vescovi, P	1
Boychuk, SI; Dedkov, AG; Yugrinova, LG	1
Arima, S; Hayakawa, K; Hoshinaga, K; Kusaka, M; Maruyama, T; Miyakawa, S; Mori, S; Sasaki, H; Shiroki, R	1
Chow, E; Ehrlich, L; Hird, AE; Ko, YJ; Probyn, L; Sinclair, E; Yip, D	1
Fujii, Y; Fukui, I; Kijima, T; Masuda, H; Okubo, Y; Suyama, T; Yamamoto, S; Yonese, J	1
Costa, F; Kalkner, KM; Lennartsson, L; Lennernas, B; Linder, S; Nilsson, S; Sandstrom, P; Schwarz, S; Ullen, A	1
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B	1
Izumi, K; Konaka, H; Miwa, S; Mizokami, A; Namiki, M; Nohara, T	1
Hasegawa, Y; Matsubara, A; Mita, K; Ohdan, H	1
Kobayashi, H; Minato, N; Shimmura, H; Tanabe, K; Tanaka, Y	1
Bozas, G; Maraveyas, A; Ramasamy, V; Roy, A	1
Eastham, JA; Saad, F	1
Botteman, MF; Chen, YM; Foley, I; Kaura, S; Meijboom, M; Stephens, JM	1
Cagli, B; Intagliata, S; Onetti Muda, A; Perrone, G; Persichetti, P; Santini, D; Segreto, F; Tonini, G	1
Brown, J; Clark, K; Gregory, W; Hayward, K; Jagdev, S; McParland, L; Newsham, A; Rogerson, S; Selby, P; Woodward, E	1
Kobayashi, H; Minato, N; Tanabe, K; Tanaka, Y; Yagi, J	1
Eickhoff, JC; Horvath, DL; Kaikobad, MR; Lang, JM; Liu, G; Malkovsky, M; McNeel, DG; Staab, MJ; Wallace, M; Wilding, G	1
Haygood, TM; Jonasch, E; Manoukian, GE; Qiao, W; Tannir, NM; Tu, SM	1
Fujita, M; Nakamura, T; Okamura, N; Sawada, K; Tohi, M; Yagami, T; Yamamori, M; Yamamoto, Y	1
Botteman, MF; Carter, JA; Joshi, AD; Kaura, S	1
Birkholz, K; Gruenwald, V; Kindler, M; May, C; Miller, K; Ruebel, A; Schultze-Seemann, W; Schulze, M; Stenzl, A; Strauss, A; Tunn, UW; Wirth, MP; Zantl, N	1
Chen, AH; Tu, SM	1
Boikos, SA; Hammers, HJ	1
Fujii, Y; Fukui, I; Kitsukawa, S; Takahashi, S; Urakami, S; Yamamoto, S; Yasuda, Y; Yonese, J; Yuasa, T	1
Hiraga, H; Isu, K; Kamata, H; Minami, A; Shinohara, N; Takeda, N	1
Lipton, A; Seaman, J; Zheng, M	1
La Cesa, A; Santini, D; Tonini, G; Vincenzi, B	1
Bukowski, RM; Colombo-Berra, A; Lipton, A; Rosen, L; Urbanowitz, G; Zheng, M	1
Michaelson, MD; Rosenthal, DI; Smith, MR	1
Ciccarelli, R; Fedele, S; Lo Muzio, L; Lo Russo, L; Mignogna, MD	1
Do, KA; Jonasch, E; Lin, P; Lin, SH; Mathew, P; Pagliaro, LC; Rhines, L; Siefker-Radtke, A; Tannir, N; Tibbs, R; Tu, SM	1
Anderson, C; Birchall, L; Harrington, K; Meyer, B; Pandha, H; Relph, K; Wilson, N	1
Newman, SA; Phillips, PM	1
Fujii, Y; Fukui, I; Kijima, T; Okubo, Y; Suyama, T; Yonese, J	1

Reviews

6 review(s) available for zoledronic acid and Adenocarcinoma Of Kidney

Article	Year
Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to bone. Anti-cancer drugs, 2013, Volume: 24, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Sunitinib; Vascular Endothelial Growth Factor A; Zoledronic Acid	2013
Treatment of bone metastases in urologic malignancies. Urologia internationalis, 2014, Volume: 93, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cisplatin; Denosumab; Diphosphonates; Humans; Imidazoles; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prostatic Neoplasms; Quality of Life; Radiosurgery; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms; Zoledronic Acid	2014
Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature. Clinical genitourinary cancer, 2015, Volume: 13, Issue:4 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Indoles; Italy; Jaw; Kidney Neoplasms; Male; Middle Aged; Osteonecrosis; Pyrroles; Retrospective Studies; Sunitinib; Zoledronic Acid	2015
Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer. Seminars in oncology, 2010, Volume: 37 Suppl 1 Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease Progression; Humans; Imidazoles; Kidney Neoplasms; Survival Analysis; Urinary Bladder Neoplasms; Zoledronic Acid	2010
Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours. PharmacoEconomics, 2012, Volume: 30, Issue:5 Topics: Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Carcinoma, Renal Cell; Cost-Benefit Analysis; Diphosphonates; Drug Costs; Europe; Health Care Costs; Humans; Imidazoles; Kidney Neoplasms; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Zoledronic Acid	2012
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Sep-15, Volume: 10, Issue:18 Pt 2 Topics: Bone Diseases; Bone Neoplasms; Bone Resorption; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Neoplasm Metastasis; Osteolysis; Zoledronic Acid	2004

Trials

9 trial(s) available for zoledronic acid and Adenocarcinoma Of Kidney

Article	Year
A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma. Japanese journal of clinical oncology, 2021, Jan-01, Volume: 51, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Treatment Outcome; Zoledronic Acid	2021
Everolimus and zoledronic acid in patients with renal cell carcinoma with bone metastases: a randomized first-line phase II trial. Clinical genitourinary cancer, 2015, Volume: 13, Issue:1 Topics: Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Collagen Type I; Diphosphonates; Everolimus; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Peptides; Prospective Studies; Sirolimus; Treatment Outcome; Zoledronic Acid	2015
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma. Cancer immunology, immunotherapy : CII, 2011, Volume: 60, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; CD3 Complex; Cytotoxicity, Immunologic; Diphosphonates; Female; Humans; Imidazoles; Immunotherapy, Adoptive; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Lymphocyte Activation; Male; Middle Aged; Neoplasm Staging; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Zoledronic Acid	2011
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma. Cancer immunology, immunotherapy : CII, 2011, Volume: 60, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Separation; Diphosphonates; Female; Flow Cytometry; Humans; Imidazoles; Immunotherapy; Interleukin-2; Kidney Neoplasms; Lymphocyte Activation; Male; Middle Aged; Pilot Projects; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Zoledronic Acid	2011
Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma. Clinical genitourinary cancer, 2011, Volume: 9, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Biomarkers, Tumor; Bone Neoplasms; Bone Remodeling; Carcinoma, Renal Cell; Diphosphonates; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Pilot Projects; Pyrroles; Zoledronic Acid	2011
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases. The Canadian journal of urology, 2012, Volume: 19, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Fractures, Spontaneous; Humans; Imidazoles; Kaplan-Meier Estimate; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Spinal Cord Compression; Tomography, X-Ray Computed; Zoledronic Acid	2012
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma. Cancer, 2003, Sep-01, Volume: 98, Issue:5 Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease Progression; Female; Fractures, Bone; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Placebos; Retrospective Studies; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid	2003
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acid. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Sep-15, Volume: 10, Issue:18 Pt 2 Topics: Bone Diseases; Bone Neoplasms; Bone Resorption; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Neoplasm Metastasis; Osteolysis; Zoledronic Acid	2004
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma. Cancer, 2006, Aug-01, Volume: 107, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Interferon-gamma; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Thalidomide; Zoledronic Acid	2006

Other Studies

32 other study(ies) available for zoledronic acid and Adenocarcinoma Of Kidney

Article	Year
TIGIT-expressing zoledronate-specific γδ T cells display enhanced antitumor activity. Journal of leukocyte biology, 2022, Volume: 112, Issue:6 Topics: Carcinoma; Carcinoma, Renal Cell; Cytokines; Humans; Kidney Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Immunologic; Zoledronic Acid	2022
Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis. International journal of clinical oncology, 2018, Volume: 23, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Chemoradiotherapy; Female; Fractures, Spontaneous; Humans; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Spinal Cord Compression; Sunitinib; Survival Rate; Treatment Outcome; Zoledronic Acid	2018
Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2013, Volume: 71, Issue:9 Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cohort Studies; Diphosphonates; Everolimus; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Imidazoles; Indazoles; Indoles; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Radiography, Panoramic; Retrospective Studies; Sirolimus; Sorafenib; Spinal Cord Compression; Sulfonamides; Sunitinib; Survival Rate; Zoledronic Acid	2013
Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1. PloS one, 2013, Volume: 8, Issue:5 Topics: Apoptosis; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; Diphosphonates; Gamma Rays; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Kidney Neoplasms; Organ Specificity; Radiation Tolerance; Radiation-Sensitizing Agents; RNA, Small Interfering; Signal Transduction; STAT1 Transcription Factor; Zoledronic Acid	2013
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:9 Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Glutamates; Guanine; Humans; Imidazoles; Indoles; Interferons; Kidney Tubules; Lung Neoplasms; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Necrosis; Nephrectomy; Pemetrexed; Prednisone; Pyrroles; Sunitinib; TOR Serine-Threonine Kinases; Vincristine; Zoledronic Acid	2013
Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study. British journal of cancer, 2013, Jul-09, Volume: 109, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Bone Remodeling; Carcinoma, Renal Cell; Collagen Type I; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Peptide Fragments; Procollagen; Prospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Zoledronic Acid	2013
Jaw lesion and discomfort. JAMA, 2013, Nov-27, Volume: 310, Issue:20 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Carcinoma, Renal Cell; Chlorhexidine; Diphosphonates; Doxycycline; Female; Gingival Diseases; Humans; Imidazoles; Kidney Neoplasms; Mandible; Middle Aged; Mouthwashes; Oral Hygiene; Pain; Zoledronic Acid	2013
Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma. European urology, 2014, Volume: 66, Issue:3 Topics: Aged; Antineoplastic Agents; Axitinib; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease-Free Survival; Female; Humans; Hypocalcemia; Imidazoles; Indazoles; Indoles; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Pamidronate; Phenylurea Compounds; Prognosis; Pyrroles; Renal Insufficiency; Retrospective Studies; Sirolimus; Sorafenib; Sunitinib; Survival Rate; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Zoledronic Acid	2014
[PREVENTION OF THE BONES METASTASES OCCURRENCE IN THE PATIENTS WITH RENAL-CELL CANCER]. Klinichna khirurhiia, 2015, Issue:12 Topics: Acid Phosphatase; Aged; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Drug Administration Schedule; Female; Gene Expression; Humans; Imidazoles; Isoenzymes; Kidney Neoplasms; Male; Middle Aged; Radiography; Tartrate-Resistant Acid Phosphatase; Tomography, Emission-Computed; Treatment Outcome; Zoledronic Acid	2015
[Zoledronic acid for bone metastases due to advanced renal cell carcinoma under chronic hemodialysis--a report of two cases]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2008, Volume: 99, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Carcinoma, Renal Cell; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Infusions, Intravenous; Interleukin-2; Kidney Failure, Chronic; Kidney Neoplasms; Male; Middle Aged; Monitoring, Physiologic; Renal Dialysis; Thalidomide; Zoledronic Acid	2008
Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature. Journal of palliative medicine, 2008, Volume: 11, Issue:8 Topics: Adult; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Diphosphonates; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Nephrectomy; Pain Management; Palliative Care; Pyrroles; Quality of Life; Sunitinib; Zoledronic Acid	2008
Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU international, 2009, Volume: 103, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Combined Modality Therapy; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Zoledronic Acid	2009
Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines. Scandinavian journal of urology and nephrology, 2009, Volume: 43, Issue:2 Topics: Apoptosis; Bone Density Conservation Agents; Carcinoma, Renal Cell; Caspases; Cell Line, Tumor; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme-Linked Immunosorbent Assay; Fluorometry; Humans; Imidazoles; Kidney Neoplasms; Zoledronic Acid	2009
[Primary hyperparathyroidism. An alternative to the surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3 Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid	2009
A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy. Japanese journal of clinical oncology, 2009, Volume: 39, Issue:11 Topics: Adult; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Pleural Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2009
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient. International journal of clinical oncology, 2009, Volume: 14, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Immunosuppressive Agents; Incidental Findings; Interferon-alpha; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Nephrectomy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Radiotherapy, Adjuvant; Sorafenib; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2009
Complete remission of lung metastasis following adoptive immunotherapy using activated autologous gammadelta T-cells in a patient with renal cell carcinoma. Anticancer research, 2010, Volume: 30, Issue:2 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Carcinoma, Renal Cell; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Immunotherapy, Adoptive; Interferon-gamma; Interleukin-2; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; T-Lymphocytes; Transplantation, Autologous; Treatment Outcome; Zoledronic Acid	2010
Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib. Onkologie, 2010, Volume: 33, Issue:6 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Diphosphonates; Drug Synergism; Humans; Imidazoles; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Mandibular Diseases; Middle Aged; Neoplasm Staging; Osteonecrosis; Pyrroles; Sacrum; Spinal Neoplasms; Sunitinib; Zoledronic Acid	2010
Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom. The European journal of health economics : HEPAC : health economics in prevention and care, 2011, Volume: 12, Issue:6 Topics: Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cost-Benefit Analysis; Diphosphonates; Female; Financing, Government; France; Germany; Humans; Imidazoles; Male; Models, Economic; Neoplasm Staging; Quality-Adjusted Life Years; Retrospective Studies; Sensitivity and Specificity; Severity of Illness Index; United Kingdom; Zoledronic Acid	2011
Recurrent scrotal hemangiomas during treatment with sunitinib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-10, Volume: 28, Issue:35 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Genital Neoplasms, Male; Hemangioma; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Recurrence; Scrotum; Skin Neoplasms; Sunitinib; Zoledronic Acid	2010
Skeletal complications and survival in renal cancer patients with bone metastases. Bone, 2011, Volume: 48, Issue:1 Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Spinal Cord Compression; Survival Analysis; Time Factors; Zoledronic Acid	2011
Involvement of the mevalonate pathway in the antiproliferative effect of zoledronate on ACHN renal cell carcinoma cells. Oncology reports, 2012, Volume: 27, Issue:5 Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Male; Metabolic Networks and Pathways; Mevalonic Acid; Mice; Mice, Inbred BALB C; Xenograft Model Antitumor Assays; Zoledronic Acid	2012
Re: Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases. The Canadian journal of urology, 2012, Volume: 19, Issue:3 Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Zoledronic Acid	2012
Denosumab for the treatment of bisphosphonate-refractory hypercalcemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Oct-10, Volume: 30, Issue:29 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Carcinoma, Renal Cell; Denosumab; Diphosphonates; Disease Progression; Drug Resistance; Fatal Outcome; Humans; Hypercalcemia; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Parathyroid Hormone; Risk Assessment; Zoledronic Acid	2012
Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma. International journal of clinical oncology, 2013, Volume: 18, Issue:5 Topics: Aged; Bone Neoplasms; Calcium; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Zoledronic Acid	2013
Zoledronic acid enhances the effect of radiotherapy for bone metastases from renal cell carcinomas: more than a 24-month median follow-up. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2012, Volume: 17, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Retrospective Studies; Young Adult; Zoledronic Acid	2012
Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma. Cancer, 2004, May-01, Volume: 100, Issue:9 Topics: Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Kidney Neoplasms; Male; Neoplasm Staging; Prognosis; Sampling Studies; Survival Analysis; Treatment Outcome; Zoledronic Acid	2004
Long-term bisphosphonate treatment of bone metastases from renal cell carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Oct-15, Volume: 22, Issue:20 Topics: Aged; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Male; Zoledronic Acid	2004
Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Mar-20, Volume: 24, Issue:9 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Hyperbaric Oxygenation; Imidazoles; Jaw; Kidney Neoplasms; Male; Osteonecrosis; Pain; Zoledronic Acid	2006
Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines. The Journal of urology, 2006, Volume: 176, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Pamidronate; Tumor Cells, Cultured; Zoledronic Acid	2006
Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:1 Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Glucocorticoids; Humans; Imidazoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Orbital Pseudotumor; Prednisone; Tomography, X-Ray Computed; Zoledronic Acid	2008
Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report. International journal of urology : official journal of the Japanese Urological Association, 2008, Volume: 15, Issue:6 Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Pamidronate; Zoledronic Acid	2008